Related Experiment Videos
Helicobacter pylori-negative duodenal ulcer
Y M Nensey1, T T Schubert, S D Bologna
1Division of Gastroenterology, Henry Ford Hospital, Detroit, Michigan 48202.
The American Journal of Medicine
|July 1, 1991
Summary
Helicobacter pylori (HP) status impacts duodenal ulcer (DU) mechanisms. HP-negative DU patients are more likely aspirin users, while HP-positive patients show more inflammation, suggesting different treatment approaches.
Area of Science:
- Gastroenterology
- Microbiology
- Pathophysiology
Background:
- Helicobacter pylori (HP) is implicated in over 90% of duodenal ulcers (DUs).
- Understanding pathophysiology in HP-negative DUs is crucial for effective treatment.
Purpose of the Study:
- To compare the characteristics and pathophysiology of HP-negative duodenal ulcers (DUs) with those of HP-positive DUs.
- To identify distinct risk factors and clinical presentations associated with HP-negative versus HP-positive DUs.
Main Methods:
- Consecutive duodenal ulcer patients were interviewed pre-endoscopy about ulcer disease risk factors.
- Antral biopsy specimens were collected during esophagogastroduodenoscopy for HP detection (urease test, culture, Warthin Starry staining).
Main Results:
- HP-negative DU patients were more frequent aspirin users and had fewer prior ulcers compared to HP-positive patients.
- HP-positive DU patients exhibited more severe antral inflammation.
- Whites were more likely to be HP-negative; HP-negative DUs commonly presented with bleeding, while HP-positive DUs presented with pain.
Conclusions:
- Findings suggest distinct pathophysiological mechanisms for HP-positive and HP-negative duodenal ulcers.
- The absence of HP warrants a comprehensive investigation for alternative causes like NSAID/aspirin use or Zollinger-Ellison syndrome.